Related Experiment Video
Updated: Nov 18, 2025

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Autosomal Recessive Polycystic Kidney Disease-The Clinical Aspects and Diagnostic Challenges
Dorota Wicher1, Łukasz Obrycki2, Irena Jankowska3
1Department of Medical Genetics, Children's Memorial Health Institute, Warsaw, Poland.
Insights
Autosomal recessive polycystic kidney disease (ARPKD) diagnosis in children is complex due to its varied symptoms. Genetic testing is crucial for identifying the molecular basis and aiding differential diagnosis.
Area of Science:
- Pediatric Nephrology
- Medical Genetics
- Ciliopathies
Background:
- Autosomal recessive polycystic kidney disease (ARPKD) is a common ciliopathy affecting kidneys and liver.
- Clinical manifestations include nephromegaly, hypertension, renal dysfunction, congenital hepatic fibrosis, and neurocognitive impairment.
- A multidisciplinary approach is necessary for managing ARPKD patients.
Purpose of the Study:
- To discuss the role of genetic testing in diagnosing ARPKD in children.
- To highlight the challenges associated with genetic testing for ARPKD.
Main Methods:
- Review of current diagnostic criteria for ARPKD.
- Analysis of the utility and limitations of genetic testing in pediatric ARPKD cases.
Main Results:
- Genetic testing reveals the molecular heterogeneity of ARPKD.
- Differential diagnosis is essential due to overlapping clinical features.
- Genetic testing is becoming indispensable for accurate ARPKD diagnosis.
Conclusions:
- Genetic testing plays a pivotal role in the accurate diagnosis of ARPKD in children.
- Overcoming diagnostic challenges requires understanding the genetic basis of ARPKD.
- Genetic insights are vital for improving patient care and management strategies.
Abstract:
Autosomal recessive polycystic kidney disease (ARPKD) is one of the most common ciliopathies with kidney (nephromegaly, hypertension, renal dysfunction) and liver involvement (congenital hepatic fibrosis, dilated bile ducts). Clinical features also include growth failure and neurocognitive impairment. Plurality of clinical aspects requires multidisciplinary approach to treatment and care of patients. Until recently, diagnosis was based on clinical criteria. Results of genetic testing show the molecular basis of polycystic kidneys disease is heterogeneous, and differential diagnosis is essential. The aim of the article is to discuss the role of genetic testing and its difficulties in diagnostics of ARPKD in children.
More Related Videos
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Nephrons
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Nephrotic Syndrome I : Introduction

